Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(21):1562-1563; doi:10.1093/jnci/dji392
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Finkelstein, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Finkelstein, J. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Sharks Do Get Cancer: Few Surprises in Cartilage Research

Joel B. Finkelstein

The first 10% of the full text of this article appears below.

As is the case for many alternative remedies, dozens of shark cartilage products for a variety of medical conditions are already on the market despite a lack of strong clinical evidence to support their effectiveness.

Although some laboratory studies have shown that shark cartilage may have antiangiogenic properties, it remains unclear whether future research will ultimately clarify troubling questions created by early human trials, some of which included a mixture of scientific conjecture and product promotion.

Folk remedies often carry the weight of convincing anecdotal experience, but the public interest in shark cartilage has been driven more by marketing than science, said Gary K. Ostrander, Ph.D., vice chancellor for research and graduate . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?